Article Details

HLS Therapeutics' (HLS) Buy Rating Reiterated at Clarus Securities - Defense World

Retrieved on: 2022-04-27 16:30:52

Tags for this article:

Click the tags to see associated articles and topics

HLS Therapeutics' (HLS) Buy Rating Reiterated at Clarus Securities - Defense World. View article details on hiswai:

Excerpt

HLS Therapeutics (TSE:HLS – Get Rating)'s stock had its “buy” rating restated by equities researchers at Clarus Securities in a report issued on ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up